1,2,4-基抗癌剂的最新进展:结构优化,机制和治疗潜力 (2022-2025)
Nafeesa Naeem1, Ehsan Ullah Mughal1, Amina Sadiq2
1Department of Chemistry, University of Gujrat, Gujrat, Pakistan.
Archiv der Pharmazie
|July 29, 2025
概括
1,2,4-三化合物通过抑制关键酶和通路,显示出作为抗癌剂的前途. 最近的进展着重于优化它们的结构-活性关系,以提高癌症治疗的疗效和选择性.
科学领域:
- 药用化学 医学化学
- 药物发现 药物发现 药物发现
- 在瘤学瘤学.
背景情况:
- 1,2,4-二醇支架是开发抗癌药物的关键异环核心.
- 其独特的特性促进了生物利用性和多样化的生物活动.
- 最近的研究重点是优化结构-活动关系 (SARs).
研究的目的:
- 为在2022-2025年期间开发的基于1,2,4-triazole的抗癌药物提供全面的概述.
- 强调它们的作用机制,分子点和治疗潜力.
- 要突出最近的SAR趋势和修改,以增强抗癌功效.
主要方法:
- 关于1,2,4-三抗癌剂的最新文献 (2022-2025) 的综述.
- 对1,2,4-triazole核心的修改及其对疗效的影响的分析.
- 检查有关酶抑制,DNA相互作用和亡/自调节的研究.
主要成果:
- 1,2,4-三衍生物通过抑制激酶,碳酸无水酶和拓酶酶,表现出强烈的抗癌活性.
- 这些化合物干扰DNA,调节亡和自的途径.
- 新兴的SAR趋势显示,特定的功能组增强了效能和选择性.
结论:
- 1,2,4-三醇药对抗癌药物发现至关重要.
- 最近的衍生品显示出显著的治疗潜力,正在进行体内和临床评估.
- 需要进一步的研究来将合理的药物设计转化为临床应用.
关键词:
第111章 这是一件好事2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 3 3 4 1 2 2 2 2 2 2 2 2 2 2 2 2 14-三醇的使用情况这是一种抗癌药物.杂交的异环化合物 杂交的异环化合物结构活动关系结构活动关系相关概念视频
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Cancer Therapies
8.0K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.0K
Structure-Activity Relationships and Drug Design
1.1K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.1K
Drugs that Destabilize Microtubules
2.0K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
2.0K
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Drugs that Stabilize Microtubules
2.1K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K


